Perspective Therapeutics (CATX) Non-Current Debt (2023 - 2026)

Perspective Therapeutics has disclosed Non-Current Debt across 4 years of filings, most recently posting $1.6 million for Q1 2026.

• Non-Current Debt for Q1 2026 came in at $1.6 million, down 3.54% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 million (down 3.54% YoY), and the FY2025 annual result was $1.6 million, down 3.45% from the prior year.
• Non-Current Debt came in at $1.6 million for Q1 2026 at Perspective Therapeutics, down from $1.6 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $1.7 million in Q1 2023 to a low of $1.6 million in Q1 2026.
• The 4-year median for Non-Current Debt is $1.6 million (2024), against an average of $1.6 million.
• Across the five-year window, Non-Current Debt decreased 2.92% in 2024 and declined 3.54% in 2026, its largest moves.
• Perspective Therapeutics' Non-Current Debt stood at $1.7 million in 2023, then fell by 3.04% to $1.6 million in 2024, then decreased by 3.45% to $1.6 million in 2025, then dropped by 0.96% to $1.6 million in 2026.
• The last three Non-Current Debt figures came in at $1.6 million (Q1 2026), $1.6 million (Q4 2025), and $1.6 million (Q3 2025), per Business Quant data.